Joe Rogan, Kirstie Alley, and a handful of other celebrities have brought out the anti-Ivermectin wolves in America. Mainstream media is in full attack-mode. Big Tech is censoring posts to the point that people are coming up with creative ways to indicate they’re even talking about Ivermectin so as not to trigger the filters. The CDC claimed the drug was for horses only, neglecting to remove their own recommendations for people to take Ivermectin for other issues.
If the CDC is recommending what they deemed to be a “horse dewormer” to people traveling from Africa, does that mean the CDC is racist?
A graph made its rounds on social media yesterday that raised some eyebrows. It showed the clear difference between countries in Africa that use Ivermectin regularly versus those that do not. The differences were startling as the Ivermectin-nations showed unambiguous advantages against Covid-19. The mortality rates were very low compared to countries that do not use Ivermectin on a wide scale.
This graph prompted me to dig deeper into the study. As it turned out, the graph is the tip of the iceberg. There are other data points supporting the use of Ivermectin as a treatment for Covid-19 scattered throughout the study. I’ll publish the whole thing below, but here are some important takeaways for easy digestion.
First, the countries that use Ivermectin have less-sophisticated medical facilities than the nations that do not use Ivermectin. This means that life expectancy is lower and testing is more sporadic. Universal Ivermectin use seems to be the only factor preventing these nations from a full-blown Covid-19 catastrophe.
Second, Africa seems to be the perfect environment for this type of study because of the stark differences in mortality rates. Nations that push Ivermectin as an antiparasitic agent were not attempting to fight Covid-19. They’ve been using the drug universally for years. Therefore, the data regarding mortality clearly delineates between Ivermectin nations and non-Ivermectin nations. As the study states, “The community-directed onchocerciasis treatment with ivermectin is the most reasonable explanation for the decrease in morbidity and fatality rate in Africa.”
The final and arguably most important “hidden” takeaway from the study is that recovery and fatality rates for Covid-19 cases were not statistically significantly different between Ivermectin countries and non-Ivermectin countries. That means that once a person was tested and officially declared a Covid-19 case, they recovered or died at essentially the same rates across the board.
This tells us that other factors such as medical proficiency, environmental differences, or access to vaccines do not contribute to whether someone lives or dies once they have become sick with the disease. Since overall mortality rates per capita are significantly lower in Ivermectin nations but case fatality rates are the same, Ivermectin is clearly effective as an early treatment and perhaps even as a preventative measure.